Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998).
Magrini SM, Bertoni F, Vavassori V, Villa S, Cagna E, Maranzano E, Pertici M, Pradella R, Spediacci MA, Chiavacci A, Ambrosi E, Livi L, Magli A, Bellavita R, Bossi A, Biti G. Magrini SM, et al. Among authors: bossi a. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1310-9. doi: 10.1016/s0360-3016(01)02783-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955744
Random forests to predict rectal toxicity following prostate cancer radiation therapy.
Ospina JD, Zhu J, Chira C, Bossi A, Delobel JB, Beckendorf V, Dubray B, Lagrange JL, Correa JC, Simon A, Acosta O, de Crevoisier R. Ospina JD, et al. Among authors: bossi a. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1024-1031. doi: 10.1016/j.ijrobp.2014.04.027. Epub 2014 Jul 8. Int J Radiat Oncol Biol Phys. 2014. PMID: 25035205 Clinical Trial.
Elective nodal radiotherapy in prostate cancer.
De Meerleer G, Berghen C, Briganti A, Vulsteke C, Murray J, Joniau S, Leliveld AM, Cozzarini C, Decaestecker K, Rans K, Fonteyne V, De Hertogh O, Bossi A. De Meerleer G, et al. Among authors: bossi a. Lancet Oncol. 2021 Aug;22(8):e348-e357. doi: 10.1016/S1470-2045(21)00242-4. Lancet Oncol. 2021. PMID: 34339655 Review.
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy.
Martini A, Fossati N, Karnes RJ, Boorjian SA, Boeri L, Bossi A, Di Muzio N, Cozzarini C, Noris Chiorda B, Gandaglia G, Robesti D, Bartkowiak D, Böhmer D, Shariat SF, Goldner G, Battaglia A, Joniau S, Berghen C, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Wiegel T, Briganti A. Martini A, et al. Among authors: bossi a. Eur Urol Oncol. 2021 Apr;4(2):301-304. doi: 10.1016/j.euo.2019.11.003. Epub 2019 Dec 4. Eur Urol Oncol. 2021. PMID: 31810893 Clinical Trial.
476 results